Akorn Inc. News
Generic-Drug Maker Akorn Files Chapter 11
Generic-drug maker Akorn filed a Chapter 11 petition. A deal with its lenders will enable it to continue a search for a buyer.
Drugmaker Akorn Receives FDA Warning Letter Regarding N.J. Facility
Akorn receives a warning letter from the U.S. Food & Drug Administration regarding an inspection of the company's facility in Somerset, New Jersey.
Dow Loses Steam as Yields Hover Near 3% Threshold
The S&P 500 finished slightly higher, up just 0.01%.
Akorn's Stock Crashes as Germany's Fresenius Ends Takeover Amid Data Allegations
Akorn shares plummeted Monday after Germany's Fresenius Medical ditched its planned $5 billion takeover amid allegations of data misconduct at the Lake Forest, Ill.-based generic drugmaker.
Alphabet Earnings and 4 Other Business Stories You Must Know Monday Morning
Happy Monday! These are the headlines you need to see during your morning commute.
Alphabet Earnings, Bond Yields Rise, Akorn Plunges - 5 Things You Must Know
Stock futures are mostly lower as benchmark 10-year Treasury notes inch closer to 3%; Google parent Alphabet, T-Mobile US and Hasbro report earnings; Akorn plunges after Germany's Fresenius drops its planned $5 billion takeover of the generic drugmaker.
Global Stocks Slip as 3% 10-Year Yields, Bad Tech News Unsettle Markets
The U.S. earnings seasons accelerates this week with 180 S&P 500 companies reporting, including big tech names such as Google, Facebook, Amazon and Microsoft.
Akorn Shares Plunge After Fresenius Warns on Takeover Amid Data Breach Probe
Germany's Fresenius SE said a probe into alleged data breaches at Akorn could scupper its planned $5 billion takeover of the Lake Forest, Ill.-based generic drugmaker.
Stock Futures Improve After Fed's Powell Repeats 'Gradual' Rate Hike Aim
Global stocks were mixed in early Tuesday trading as investors sifted through prepared remarks ahead of the first of two appearances on Capitol Hill this week by new Fed chairman Jerome Powell.
Teva, Mylan Seen to Stay on M&A Sidelines
Teva is 'in no shape' to be making acquisitions while Mylan is 'still pretty leveraged,' says Oppenheimer analyst Derek Archila.
Breaking News
How Airlines May Revive Fast Air Travel at More Reasonable Price
American Airlines is buying 20 supersonic jets from Boom Supersonic.
Taking Social Security? Retirees May Get a Big COLA Bump Up in 2023.
U.S. retirees may get a big benefit with the next Social Security cost-of-living adjustment for 2023.
Wendy's Follows McDonald's in Making a Huge Change
Restaurants are moving to adapt to customers with very different wants and desires.
Famed Investor Druckenmiller Dumps Amazon
Stanley Druckenmiller, a former colleague of George Soros, bought and sold several stocks in the second quarter.